This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Moderna Inc. (MRNA) advanced 3.23% to $331.88 Thursday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.73% to 14,823.43 and the Dow Jones Industrial Average rising 1.56% to 34,912.56. This was the stock's fourth consecutive day of gains. Moderna Inc. closed $165.61 below its 52-week high ($497.49), which the company reached on August 10th.
The stock outperformed some of its competitors Thursday, as AbbVie Inc. (ABBV) rose 1.57% to $108.91, Amgen Inc. (AMGN) rose 1.56% to $206.78, and AstraZeneca PLC ADR (AZN.LN) fell 1.29% to $59.67. Trading volume (12.5 M) remained 4.4 million below its 50-day average volume of 16.9 M.
Data source: Dow Jones Market Data, FactSet. Data compiled October 14, 2021.
(END) Dow Jones Newswires
October 14, 2021 16:31 ET (20:31 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.